The government is all set to provide relief to patients by expanding the coverage of its Jan Aushadhi scheme. As […]
Indian pharmaceutical sector is facing regulatory hurdles in the international markets, including the US, due to shortage of skilled drug […]
BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics
BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics, today announced that it ...
NeoBiocon, a collaboration between Asia’s leading biopharmaceuticals company Biocon Ltd and Dr. B.R. Shetty, Chairman of the UAE-based Neopharma, anno...
A whopping $150 billion amount will form the world’s largest pharma entity; after Pfizer Inc. and Allergan PLC board members likely […]
NPPA had earlier identified and prepared a list of fixing the price for 98 drugs used for treating various diseases […]
After the falling business of its flagship drug Rebif, used for multiple sclerosis, Merck KGaA is now betting its fortunes […]